+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
DNA & Gene Chip Market - Global Forecast to 2030- Product Image
DNA & Gene Chip Market - Global Forecast to 2030- Product Image
New

DNA & Gene Chip Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083536
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The DNA & Gene Chip Market grew from USD 9.71 billion in 2024 to USD 10.84 billion in 2025. It is expected to continue growing at a CAGR of 11.46%, reaching USD 18.63 billion by 2030.

The DNA and gene chip arena has emerged as a cornerstone of modern life sciences, driving innovation across clinical diagnostics, academic research and biotechnology. As genomic technologies evolve, these platforms enable researchers and clinicians to decode complex biological systems with unprecedented resolution. From early microarray experiments revealing gene expression patterns to next-generation sequencing pipelines unmasking genomic variants, this ecosystem continually expands its capabilities. Emerging digital tools and advanced bioinformatics frameworks now streamline data interpretation, accelerating translational research and personalized medicine initiatives. Stakeholders across the value chain-including instrument vendors, service providers and end users-must navigate a dynamic environment shaped by technological convergence, regulatory oversight and shifting supply chains. This executive summary offers a cohesive overview, guiding decision-makers through critical developments, segmentation strategies, regional dynamics and competitive forces. By synthesizing the latest industry intelligence, it lays the foundation for informed strategic planning and operational excellence.

Transformative Shifts in the DNA & Gene Chip Landscape

Over the past decade, transformative shifts have redefined the DNA and gene chip landscape. Converging innovations in hybridization and sequencing technologies catalyze hybrid workflows that blend microarray precision with deep-sequencing sensitivity. Artificial intelligence and machine learning algorithms now power real-time pattern recognition, enabling automated anomaly detection in gene expression profiling and copy number analysis. Cloud-based platforms facilitate collaborative research, while edge computing solutions handle large-scale genomic datasets closer to the point of collection. Meanwhile, single-cell analysis has matured, allowing researchers to resolve cellular heterogeneity with microfluidic-driven Gene Expression Profiling. Regulatory frameworks have adapted, streamlining approval pathways for integrated diagnostic assays. Supply chains are also evolving: stakeholders are diversifying raw material sources and forging regional manufacturing hubs to mitigate geopolitical risks. As a result, agility and interoperability have become strategic imperatives, pushing vendors to design modular, upgradeable platforms that anticipate the next wave of multi-omics integration.

Cumulative Impact of United States Tariffs Beginning 2025

Beginning in 2025, newly imposed tariffs on imported gene chip arrays and associated reagents are reshaping cost structures across R&D and clinical laboratories. Laboratories that once relied on offshore manufacturing for cDNA microarrays and oligonucleotide microarrays face elevated unit costs, prompting procurement teams to negotiate long-term supply contracts or pivot toward domestic producers. Hybridization-based product portfolios such as single-color and two-color microarrays have borne a disproportionate share of duties, intensifying pressure on margins. In parallel, sequencing-based segments-particularly next-generation sequencing instruments-have experienced extended lead times as suppliers reconfigure logistics to accommodate tariff compliance. These headwinds have accelerated near-shoring initiatives, driving strategic alliances between molecular diagnostics providers and regional fabrication facilities. Consequently, end-users across academic and pharmaceutical sectors are reevaluating capital investments, prioritizing flexible platforms that can pivot between hybridization- and sequencing-based workflows without incurring prohibitive retraining or certification expenses.

Key Segmentation Insights into Products, Technologies, End Users, Applications and Services

Insights into segment performance reveal distinct growth drivers. Within the product typology, Bioinformatics Tools-a category encompassing DNA Sequence Alignment Tools and Gene Prediction Tools-has gained traction as organizations invest in automated analytics to derive actionable insights from complex datasets. Meanwhile, DNA Microarrays, split between cDNA Microarrays and Oligonucleotide Microarrays, retain strong relevance for high-throughput expression screening, though their adoption is moderated by sequencing-based cost curves. Gene Expression Profiling, including PCR-Based Arrays and RNA-Sequencing, continues to expand, underpinned by demand for precision oncology assays. On the technology front, Hybridization-Based systems differentiate through innovative two-color protocols that boost signal specificity, whereas Sequencing-Based platforms leverage Next-Generation Sequencing to deliver comprehensive variant detection alongside legacy Sanger Sequencing for confirmatory analysis. Across end users, Academic & Research Institutes-with a focus on Biotechnology Departments and Genomics Research Labs-drive foundational discovery, while Clinical Laboratories engage in Routine Diagnostic Testing and Specialized Genetic Screening. Government & Others entities such as Health Agencies and Regulatory Authorities continue to fund large-scale population genomics initiatives, and Pharmaceutical & Biotechnology Companies utilize Drug Development and Molecular Diagnostics workflows to support pipeline acceleration. Application-level segmentation highlights Epigenomics research targeting DNA Methylation and Histone Modification markers, Gene Expression Analysis centered on Cancer Genomics and Transcriptome Studies, Genotyping assays including Copy Number Variation and SNP Analysis, Pathogen Detection workflows for Bacterial Identification and Viral Screening, and Proteomics investigations such as Protein Expression Profiling and Protein-DNA Interaction Studies. Service-driven offerings bifurcate into Data Analysis & Interpretation services-spanning Bioinformatics Support and Biostatistical Analysis-and Manufacturing & Customization services covering Clone Arrays and Sample Preparation.

Critical Regional Developments Shaping the Market

Regional dynamics continue to animate strategic decision-making. In the Americas, well-established research infrastructure and robust funding facilitate rapid uptake of both hybridization- and sequencing-based platforms, with multi-facility consortia spearheading large-scale translational studies. Europe, Middle East & Africa benefit from harmonized regulatory frameworks that simplify cross-border collaboration in population genomics, even as localized manufacturing hubs emerge to serve high-demand markets. Asia-Pacific presents a dual narrative: mature markets in Japan and Australia drive incremental innovation in microarray sensitivity and throughput, while high-growth economies such as China and India invest heavily in domestic sequencing capacity and bioinformatics talent development. Across all regions, partnerships between local reagent suppliers and global instrument vendors are increasingly common, reducing lead times and ensuring adherence to evolving compliance standards.

Competitive Intelligence: Leading Companies Driving Innovation

Competitive intelligence underscores the pivotal roles of established and disruptive players alike. 23andMe, Inc. and Veritas Genetics, Inc. are advancing direct-to-consumer genotyping services, integrating gene chip data with personalized health reports. Agilent Technologies, Inc. and Arrayit Corporation continue to refine microarray chemistries for enhanced sensitivity. Eurofins Scientific SE and Biomérieux SA expand contract research and laboratory services, capitalizing on demand for turnkey expression profiling. Illumina, Inc. and Thermo Fisher Scientific Inc. lead the sequencing-based segment through instrument portfolios that balance throughput with accuracy. Integrated DNA Technologies and Twist Bioscience Corporation drive reagent innovation, lowering per-sample costs for library prep. Macrogen Inc. and CapitalBio Technology Co., Ltd. support academic and clinical clients with localized NGS and microarray services. Merck KGaA and Perkin Elmer, Inc. integrate bioinformatics pipelines into legacy instrumentation. Promega Corporation and Surmodics Inc. bolster assay robustness via novel sample prep chemistries. Greiner Bio-One International GmbH and Bioneer Corporation specialize in microplate and array substrates. Scienion AG by a Bico Company and Silicon Valley-based LifeGen Technologies, LLC pioneer digital dispensing and single-cell capture solutions. Shanghai Biochip Co Ltd. and Ocimum Biosolutions Ltd. address regional reagent demands, while Savyon Diagnostics and Sophia Genetics SA offer cloud-native analytics. Sysmex Corporation and Microarrays Inc. complete the ecosystem with modular automation and specialized gene chip fabrication capacities.

Actionable Recommendations for Industry Leadership

To navigate this dynamic environment, industry leaders should pursue a multi-faceted strategy. First, prioritize investment in modular platforms capable of supporting both hybridization and sequencing workflows, reducing retraining costs and future-proofing capital equipment. Second, cultivate strategic partnerships with regional manufacturers to mitigate tariff exposure and ensure uninterrupted reagent supply. Third, integrate AI-driven bioinformatics pipelines early in product roadmaps to accelerate data interpretation and deliver turnkey solutions to end users. Fourth, expand service portfolios to offer bundled packages combining sample preparation, array processing and data analysis, increasing client retention and revenue visibility. Fifth, target emerging markets by establishing local training programs and collaborative research initiatives that build domain expertise. Sixth, embed sustainability into manufacturing and logistics practices to align with corporate social responsibility goals and meet tightening environmental regulations. Finally, enhance data security protocols through end-to-end encryption and compliance audits, establishing trust for clinical and government clients handling sensitive genomic information.

Concluding Perspectives on Market Trajectory

The DNA and gene chip landscape is in constant flux, shaped by technological convergence, regulatory evolution and global supply-chain realignments. Stakeholders who embrace modularity, invest in advanced analytics and forge resilient partnerships will emerge as frontrunners. Regional diversification, coupled with a focus on sustainability and data security, ensures long-term viability. Meanwhile, competitive differentiation will hinge on the ability to deliver integrated, end-to-end solutions that address both discovery research and clinical applications. By aligning strategic roadmaps with these imperatives, organizations can capture untapped opportunities and solidify their position in a market defined by rapid innovation.

Market Segmentation & Coverage

This research report categorizes the DNA & Gene Chip Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Bioinformatics Tools
    • DNA Sequence Alignment Tools
    • Gene Prediction Tools
  • DNA Microarrays
    • cDNA Microarrays
    • Oligonucleotide Microarrays
  • Gene Expression Profiling
    • PCR-Based Arrays
    • RNA-Sequencing
  • Hybridization-Based
    • Single-Color Microarray
    • Two-Color Microarray
  • Sequencing-Based
    • Next-Generation Sequencing (NGS)
    • Sanger Sequencing
  • Academic & Research Institutes
    • Biotechnology Departments
    • Genomics Research Labs
  • Clinical Laboratories
    • Routine Diagnostic Testing
    • Specialized Genetic Screening
  • Government & Others
    • Health Agencies
    • Regulatory Authorities
  • Pharmaceutical & Biotechnology Companies
    • Drug Development
    • Molecular Diagnostics
  • Epigenomics
    • DNA Methylation
    • Histone Modification
  • Gene Expression Analysis
    • Cancer Genomics
    • Transcriptome Studies
  • Genotyping
    • Copy Number Variation
    • SNP Analysis
  • Pathogen Detection
    • Bacterial Identification
    • Viral Screening
  • Proteomics
    • Protein Expression Profiling
    • Protein-DNA Interaction Studies
  • Data Analysis & Interpretation
    • Bioinformatics Support
    • Biostatistical Analysis
  • Manufacturing & Customization
    • Clone Arrays
    • Sample Preparation Services

This research report categorizes the DNA & Gene Chip Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the DNA & Gene Chip Market to delves into recent significant developments and analyze trends in each of the following companies:

  • 23andMe, Inc.
  • Agilent Technologies, Inc.
  • Arrayit Corporation
  • Biomérieux SA
  • Bioneer Corporation
  • CapitalBio Technology Co., Ltd.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • Greiner Bio-One International GmbH
  • Illumina, Inc.
  • Integrated Dna Technologies
  • LifeGen Technologies, LLC
  • Macrogen Inc.
  • Merck KGaA
  • Microarrays Inc.
  • Ocimum Biosolutions Ltd.
  • Perkin Elmer, Inc.
  • Promega Corporation
  • Savyon Diagnostics
  • Scienion AG by a Bico Company
  • Shanghai Biochip Co Ltd.
  • Sophia Genetics SA
  • Surmodics Inc.
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation
  • Veritas Genetics, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. DNA & Gene Chip Market, by Product Type
8.1. Introduction
8.2. Bioinformatics Tools
8.2.1. DNA Sequence Alignment Tools
8.2.2. Gene Prediction Tools
8.3. DNA Microarrays
8.3.1. cDNA Microarrays
8.3.2. Oligonucleotide Microarrays
8.4. Gene Expression Profiling
8.4.1. PCR-Based Arrays
8.4.2. RNA-Sequencing
9. DNA & Gene Chip Market, by Technology Type
9.1. Introduction
9.2. Hybridization-Based
9.2.1. Single-Color Microarray
9.2.2. Two-Color Microarray
9.3. Sequencing-Based
9.3.1. Next-Generation Sequencing (NGS)
9.3.2. Sanger Sequencing
10. DNA & Gene Chip Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.2.1. Biotechnology Departments
10.2.2. Genomics Research Labs
10.3. Clinical Laboratories
10.3.1. Routine Diagnostic Testing
10.3.2. Specialized Genetic Screening
10.4. Government & Others
10.4.1. Health Agencies
10.4.2. Regulatory Authorities
10.5. Pharmaceutical & Biotechnology Companies
10.5.1. Drug Development
10.5.2. Molecular Diagnostics
11. DNA & Gene Chip Market, by Application
11.1. Introduction
11.2. Epigenomics
11.2.1. DNA Methylation
11.2.2. Histone Modification
11.3. Gene Expression Analysis
11.3.1. Cancer Genomics
11.3.2. Transcriptome Studies
11.4. Genotyping
11.4.1. Copy Number Variation
11.4.2. SNP Analysis
11.5. Pathogen Detection
11.5.1. Bacterial Identification
11.5.2. Viral Screening
11.6. Proteomics
11.6.1. Protein Expression Profiling
11.6.2. Protein-DNA Interaction Studies
12. DNA & Gene Chip Market, by Service Type
12.1. Introduction
12.2. Data Analysis & Interpretation
12.2.1. Bioinformatics Support
12.2.2. Biostatistical Analysis
12.3. Manufacturing & Customization
12.3.1. Clone Arrays
12.3.2. Sample Preparation Services
13. Americas DNA & Gene Chip Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific DNA & Gene Chip Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa DNA & Gene Chip Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. 23andMe, Inc.
16.3.2. Agilent Technologies, Inc.
16.3.3. Arrayit Corporation
16.3.4. Biomérieux SA
16.3.5. Bioneer Corporation
16.3.6. CapitalBio Technology Co., Ltd.
16.3.7. Eurofins Scientific SE
16.3.8. F. Hoffmann-La Roche AG
16.3.9. Greiner Bio-One International GmbH
16.3.10. Illumina, Inc.
16.3.11. Integrated Dna Technologies
16.3.12. LifeGen Technologies, LLC
16.3.13. Macrogen Inc.
16.3.14. Merck KGaA
16.3.15. Microarrays Inc.
16.3.16. Ocimum Biosolutions Ltd.
16.3.17. Perkin Elmer, Inc.
16.3.18. Promega Corporation
16.3.19. Savyon Diagnostics
16.3.20. Scienion AG by a Bico Company
16.3.21. Shanghai Biochip Co Ltd.
16.3.22. Sophia Genetics SA
16.3.23. Surmodics Inc.
16.3.24. Sysmex Corporation
16.3.25. Thermo Fisher Scientific Inc.
16.3.26. Twist Bioscience Corporation
16.3.27. Veritas Genetics, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. DNA & GENE CHIP MARKET MULTI-CURRENCY
FIGURE 2. DNA & GENE CHIP MARKET MULTI-LANGUAGE
FIGURE 3. DNA & GENE CHIP MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DNA & GENE CHIP MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DNA & GENE CHIP MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DNA & GENE CHIP MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DNA & GENE CHIP MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DNA & GENE CHIP MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DNA & GENE CHIP MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DNA & GENE CHIP MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DNA & GENE CHIP MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. DNA & GENE CHIP MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. DNA & GENE CHIP MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DNA & GENE CHIP MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DNA & GENE CHIP MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DNA & GENE CHIP MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DNA & GENE CHIP MARKET SIZE, BY BIOINFORMATICS TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DNA & GENE CHIP MARKET SIZE, BY DNA SEQUENCE ALIGNMENT TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DNA & GENE CHIP MARKET SIZE, BY GENE PREDICTION TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DNA & GENE CHIP MARKET SIZE, BY BIOINFORMATICS TOOLS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DNA & GENE CHIP MARKET SIZE, BY DNA MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DNA & GENE CHIP MARKET SIZE, BY CDNA MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DNA & GENE CHIP MARKET SIZE, BY OLIGONUCLEOTIDE MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DNA & GENE CHIP MARKET SIZE, BY DNA MICROARRAYS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DNA & GENE CHIP MARKET SIZE, BY GENE EXPRESSION PROFILING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PCR-BASED ARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DNA & GENE CHIP MARKET SIZE, BY RNA-SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DNA & GENE CHIP MARKET SIZE, BY GENE EXPRESSION PROFILING, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DNA & GENE CHIP MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DNA & GENE CHIP MARKET SIZE, BY HYBRIDIZATION-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DNA & GENE CHIP MARKET SIZE, BY SINGLE-COLOR MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DNA & GENE CHIP MARKET SIZE, BY TWO-COLOR MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DNA & GENE CHIP MARKET SIZE, BY HYBRIDIZATION-BASED, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DNA & GENE CHIP MARKET SIZE, BY SEQUENCING-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DNA & GENE CHIP MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS), BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DNA & GENE CHIP MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DNA & GENE CHIP MARKET SIZE, BY SEQUENCING-BASED, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DNA & GENE CHIP MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DNA & GENE CHIP MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DNA & GENE CHIP MARKET SIZE, BY BIOTECHNOLOGY DEPARTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DNA & GENE CHIP MARKET SIZE, BY GENOMICS RESEARCH LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DNA & GENE CHIP MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DNA & GENE CHIP MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DNA & GENE CHIP MARKET SIZE, BY ROUTINE DIAGNOSTIC TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DNA & GENE CHIP MARKET SIZE, BY SPECIALIZED GENETIC SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DNA & GENE CHIP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DNA & GENE CHIP MARKET SIZE, BY GOVERNMENT & OTHERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DNA & GENE CHIP MARKET SIZE, BY HEALTH AGENCIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DNA & GENE CHIP MARKET SIZE, BY REGULATORY AUTHORITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DNA & GENE CHIP MARKET SIZE, BY GOVERNMENT & OTHERS, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DNA & GENE CHIP MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DNA & GENE CHIP MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DNA & GENE CHIP MARKET SIZE, BY EPIGENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DNA & GENE CHIP MARKET SIZE, BY DNA METHYLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DNA & GENE CHIP MARKET SIZE, BY HISTONE MODIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DNA & GENE CHIP MARKET SIZE, BY EPIGENOMICS, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DNA & GENE CHIP MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DNA & GENE CHIP MARKET SIZE, BY CANCER GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DNA & GENE CHIP MARKET SIZE, BY TRANSCRIPTOME STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL DNA & GENE CHIP MARKET SIZE, BY GENE EXPRESSION ANALYSIS, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL DNA & GENE CHIP MARKET SIZE, BY GENOTYPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL DNA & GENE CHIP MARKET SIZE, BY COPY NUMBER VARIATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL DNA & GENE CHIP MARKET SIZE, BY SNP ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL DNA & GENE CHIP MARKET SIZE, BY GENOTYPING, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PATHOGEN DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL DNA & GENE CHIP MARKET SIZE, BY BACTERIAL IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL DNA & GENE CHIP MARKET SIZE, BY VIRAL SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PATHOGEN DETECTION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PROTEIN EXPRESSION PROFILING, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PROTEIN-DNA INTERACTION STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL DNA & GENE CHIP MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL DNA & GENE CHIP MARKET SIZE, BY DATA ANALYSIS & INTERPRETATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL DNA & GENE CHIP MARKET SIZE, BY BIOINFORMATICS SUPPORT, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL DNA & GENE CHIP MARKET SIZE, BY BIOSTATISTICAL ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL DNA & GENE CHIP MARKET SIZE, BY DATA ANALYSIS & INTERPRETATION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL DNA & GENE CHIP MARKET SIZE, BY MANUFACTURING & CUSTOMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL DNA & GENE CHIP MARKET SIZE, BY CLONE ARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL DNA & GENE CHIP MARKET SIZE, BY SAMPLE PREPARATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL DNA & GENE CHIP MARKET SIZE, BY MANUFACTURING & CUSTOMIZATION, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS DNA & GENE CHIP MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS DNA & GENE CHIP MARKET SIZE, BY BIOINFORMATICS TOOLS, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS DNA & GENE CHIP MARKET SIZE, BY DNA MICROARRAYS, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS DNA & GENE CHIP MARKET SIZE, BY GENE EXPRESSION PROFILING, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS DNA & GENE CHIP MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS DNA & GENE CHIP MARKET SIZE, BY HYBRIDIZATION-BASED, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS DNA & GENE CHIP MARKET SIZE, BY SEQUENCING-BASED, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS DNA & GENE CHIP MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS DNA & GENE CHIP MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS DNA & GENE CHIP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS DNA & GENE CHIP MARKET SIZE, BY GOVERNMENT & OTHERS, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS DNA & GENE CHIP MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS DNA & GENE CHIP MARKET SIZE, BY EPIGENOMICS, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS DNA & GENE CHIP MARKET SIZE, BY GENE EXPRESSION ANALYSIS, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS DNA & GENE CHIP MARKET SIZE, BY GENOTYPING, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS DNA & GENE CHIP MARKET SIZE, BY PATHOGEN DETECTION, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS DNA & GENE CHIP MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS DNA & GENE CHIP MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS DNA & GENE CHIP MARKET SIZE, BY DATA ANALYSIS & INTERPRETATION, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS DNA & GENE CHIP MARKET SIZE, BY MANUFACTURING & CUSTOMIZATION, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY BIOINFORMATICS TOOLS, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY DNA MICROARRAYS, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY GENE EXPRESSION PROFILING, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY HYBRIDIZATION-BASED, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY SEQUENCING-BASED, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY GOVERNMENT & OTHERS, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY EPIGENOMICS, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY GENE EXPRESSION ANALYSIS, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY GENOTYPING, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY PATHOGEN DETECTION, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY DATA ANALYSIS & INTERPRETATION, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY MANUFACTURING & CUSTOMIZATION, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL DNA & GENE CHIP MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL DNA & GENE CHIP MARKET SIZE, BY BIOINFORMATICS TOOLS, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL DNA & GENE CHIP MARKET SIZE, BY DNA MICROARRAYS, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL DNA & GENE CHIP MARKET SIZE, BY GENE EXPRESSION PROFILING, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL DNA & GENE CHIP MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL DNA & GENE CHIP MARKET SIZE, BY HYBRIDIZATION-BASED, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL DNA & GENE CHIP MARKET SIZE, BY SEQUENCING-BASED, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL DNA & GENE CHIP MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL DNA & GENE CHIP MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL DNA & GENE CHIP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL DNA & GENE CHIP MARKET SIZE, BY GOVERNMENT & OTHERS, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL DNA & GENE CHIP MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL DNA & GENE CHIP MARKET SIZE, BY EPIGENOMICS, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL DNA & GENE CHIP MARKET SIZE, BY GENE EXPRESSION ANALYSIS, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL DNA & GENE CHIP MARKET SIZE, BY GENOTYPING, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL DNA & GENE CHIP MARKET SIZE, BY PATHOGEN DETECTION, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL DNA & GENE CHIP MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL DNA & GENE CHIP MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL DNA & GENE CHIP MARKET SIZE, BY DATA ANALYSIS & INTERPRETATION, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL DNA & GENE CHIP MARKET SIZE, BY MANUFACTURING & CUSTOMIZATION, 2018-2030 (USD MILLION)
TABLE 139. CANADA DNA & GENE CHIP MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 140. CANADA DNA & GENE CHIP MARKET SIZE, BY BIOINFORMATICS TOOLS, 2018-2030 (USD MILLION)
TABLE 141. CANADA DNA & GENE CHIP MARKET SIZE, BY DNA MICROARRAYS, 2018-2030 (USD MILLION)
TABLE 142. CANADA DNA & GENE CHIP MARKET SIZE, BY GENE EXPRESSION PROFILING, 2018-2030 (USD MILLION)
TABLE 143. CANADA DNA & GENE CHIP MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 144. CANADA DNA & GENE CHIP MARKET SIZE, BY HYBRIDIZATION-BASED, 2018-2030 (USD MILLION)
TABLE 145. CANADA DNA & GENE CHIP MARKET SIZE, BY SEQUENCING-BASED, 2018-2030 (USD MILLION)
TABLE 146. CANADA DNA & GENE CHIP MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. CANADA DNA & GENE CHIP MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 148. CANADA DNA & GENE CHIP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 149. CANADA DNA & GENE CHIP MARKET SIZE, BY GOVERNMENT & OTHERS, 2018-2030 (USD MILLION)
TABLE 150. CANADA DNA & GENE CHIP MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 151. CANADA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. CANADA DNA & GENE CHIP MARKET SIZE, BY EPIGENOMICS, 2018-2030 (USD MILLION)
TABLE 153. CANADA DNA & GENE CHIP MARKET SIZE, BY GENE EXPRESSION ANALYSIS, 2018-2030 (USD MILLION)
TABLE 154. CANADA DNA & GENE CHIP MARKET SIZE, BY GENOTYPING, 2018-2030 (USD MILLION)
TABLE 155. CANADA DNA & GENE CHIP MARKET SIZE, BY PATHOGEN DETECTION, 2018-2030 (USD MILLION)
TABLE 156. CANADA DNA & GENE CHIP MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 157. CANADA DNA & GENE CHIP MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 158. CANADA DNA & GENE CHIP MARKET SIZE, BY DATA ANALYSIS & INTERPRETATION, 2018-2030 (USD MILLION)
TABLE 159. CANADA DNA & GENE CHIP MARKET SIZE, BY MANUFACTURING & CUSTOMIZATION, 2018-2030 (USD MILLION)
TABLE 160. MEXICO DNA & GENE CHIP MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 161. MEXICO DNA & GENE CHIP MARKET SIZE, BY BIOINFORMATICS TOOLS, 2018-2030 (USD MILLION)
TABLE 162. MEXICO DNA & GENE CHIP MARKET SIZE, BY DNA MICROARRAYS, 2018-2030 (USD MILLION)
TABLE 163. MEXICO DNA & GENE CHIP MARKET SIZE, BY GENE EXPRESSION PROFILING, 2018-2030 (USD MILLION)
TABLE 164. MEXICO DNA & GENE CHIP MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 165. MEXICO DNA & GENE CHIP MARKET SIZE, BY HYBRIDIZATION-BASED, 2018-2030 (USD MILLION)
TABLE 166. MEXICO DNA & GENE CHIP MARKET SIZE, BY SEQUENCING-BASED, 2018-2030 (USD MILLION)
TABLE 167. MEXICO DNA & GENE CHIP MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. MEXICO DNA & GENE CHIP MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 169. MEXICO DNA & GENE CHIP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 170. MEXICO DNA & GENE CHIP MARKET SIZE, BY GOVERNMENT & OTHERS, 2018-2030 (USD MILLION)
TABLE 171. MEXICO DNA & GENE CHIP MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 172. MEXICO DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. MEXICO DNA & GENE CHIP MARKET SIZE, BY EPIGENOMICS, 2018-2030 (USD MILLION)
TABLE 174. MEXICO DNA & GENE CHIP MARKET SIZE, BY GENE EXPRESSION ANALYSIS, 2018-2030 (USD MILLION)
TABLE 175. MEXICO DNA & GENE CHIP MARKET SIZE, BY GENOTYPING, 2018-2030 (USD MILLION)
TABLE 176. MEXICO DNA & GENE CHIP MARKET SIZE, BY PATHOGEN DETECTION, 2018-2030 (USD MILLION)
TABLE 177. MEXICO DNA & GENE CHIP MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 178. MEXICO DNA & GENE CHIP MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 179. MEXICO DNA & GENE CHIP MARKET SIZE, BY DATA ANALYSIS & INTERPRETATION, 2018-2030 (USD MILLION)
TABLE 180. MEXICO DNA & GENE CHIP MARKET SIZE, BY MANUFACTURING & CUSTOMIZATION, 2018-2030 (USD MILLION)
TABLE 181. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 182. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY BIOINFORMATICS TOOLS, 2018-2030 (USD MILLION)
TABLE 183. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY DNA MICROARRAYS, 2018-2030 (USD MILLION)
TABLE 184. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY GENE EXPRESSION PROFILING, 2018-2030 (USD MILLION)
TABLE 185. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 186. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY HYBRIDIZATION-BASED, 2018-2030 (USD MILLION)
TABLE 187. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY SEQUENCING-BASED, 2018-2030 (USD MILLION)
TABLE 188. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 190. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 191. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY GOVERNMENT & OTHERS, 2018-2030 (USD MILLION)
TABLE 192. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 193. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY EPIGENOMICS, 2018-2030 (USD MILLION)
TABLE 195. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY GENE EXPRESSION ANALYSIS, 2018-2030 (USD MILLION)
TABLE 196. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY GENOTYPING, 2018-2030 (USD MILLION)
TABLE 197. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY PATHOGEN DETECTION, 2018-2030 (USD MILLION)
TABLE 198. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 199. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 200. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY DATA ANALYSIS & INTERPRETATION, 2018-2030 (USD MILLION)
TABLE 201. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY MANUFACTURING & CUSTOMIZATION, 2018-2030 (USD MILLION)
TABLE 202. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY BIOINFORMATICS TOOLS, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY DNA MICROARRAYS, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY GENE EXPRESSION PROFILING, 2018-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 208. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY HYBRIDIZATION-BASED, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY SEQUENCING-BASED, 2018-2030 (USD MILLION)
TABLE 210. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 212. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 213. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY GOVERNMENT & OTHERS, 2018-2030 (USD MILLION)
TABLE 214. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 215. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY EPIGENOMICS, 2018-2030 (USD MILLION)
TABLE 217. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY GENE EXPRESSION ANALYSIS, 2018-2030 (USD MILLION)
TABLE 218. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY GENOTYPING, 2018-2030 (USD MILLION)
TABLE 219. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY PATHOGEN DETECTION, 2018-2030 (USD MILLION)
TABLE 220. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 221. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 222. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY DATA ANALYSIS & INTERPRETATION, 2018-2030 (USD MILLION)
TABLE 223. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY MANUFACTURING & CUSTOMIZATION, 2018-2030 (USD MILLION)
TABLE 224. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 225. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY BIOINFORMATICS TOOLS, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY DNA MICROARRAYS, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY GENE EXPRESSION PROFILING, 2018-2030 (USD MILLION)
TABLE 229. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 230. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY HYBRIDIZATION-BASED, 2018-2030 (USD MILLION)
TABLE 231. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY SEQUENCING-BASED, 2018-2030 (USD MILLION)
TABLE 232. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 234. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 235. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY GOVERNMENT & OTHERS, 2018-2030 (USD MILLION)
TABLE 236. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 237. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY EPIGENOMICS, 2018-2030 (USD MILLION)
TABLE 239. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY GENE EXPRESSION ANALYSIS, 2018-2030 (USD MILLION)
TABLE 240. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY GENOTYPING, 2018-2030 (USD MILLION)
TABLE 241. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY PATHOGEN DETECTION, 2018-2030 (USD MILLION)
TABLE 242. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 243. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 244. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY DATA ANALYSIS & INTERPRETATION, 2018-2030 (USD MILLION)
TABLE 245. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY MANUFACTURING & CUSTOMIZATION, 2018-2030 (USD MILLION)
TABLE 246. CHINA DNA & GENE CHIP MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 247. CHINA DNA & GENE CHIP MARKET SIZE, BY BIOINFORMATICS TOOLS, 2018-2030 (USD MILLION)
TABLE 248. CHINA DNA & GENE CHIP MARKET SIZE, BY DNA MICROARRAYS, 2018-2030 (USD MILLION)
TABLE 249. CHINA DNA & GENE CHIP MARKET SIZE, BY GENE EXPRESSION PROFILING, 2018-2030 (USD MILLION)
TABLE 250. CHINA DNA & GENE CHIP MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 251. CHINA DNA & GENE CHIP MARKET SIZE, BY HYBRIDIZATION-BASED, 2018-2030 (USD MILLION)
TABLE 252. CHINA DNA & GENE CHIP MARKET SIZE, BY SEQUENCING-BASED, 2018-2030 (USD MILLION)
TABLE 253. CHINA DNA & GENE CHIP MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 254. CHINA DNA & GENE CHIP MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 255. CHINA DNA & GENE CHIP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 256. CHINA DNA & GENE CHIP MARKET SIZE, BY GOVERNMENT & OTHERS, 2018-2030 (USD MILLION)
TABLE 257. CHINA DNA & GENE CHIP MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 258. CHINA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. CHINA DNA & GENE CHIP MARKET SIZE, BY EPIGENOMICS, 2018-2030 (USD MILLION)
TABLE 260. CHINA DNA & GENE CHIP MARKET SIZE, BY GENE EXPRESSION ANALYSIS, 2018-2030 (USD MILLION)
TABLE 261. CHINA DNA & GENE CHIP MARKET SIZE, BY GENOTYPING, 2018-2030 (USD MILLION)
TABLE 262. CHINA DNA & GENE CHIP MARKET SIZE, BY PATHOGEN DETECTION, 2018-2030 (USD MILLION)
TABLE 263. CHINA DNA & GENE CHIP MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 264. CHINA DNA & GENE CHIP MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 265. CHINA DNA & GENE CHIP MARKET SIZE, BY DATA ANALYSIS & INTERPRETATION, 2018-2030 (USD MILLION)
TABLE 266. CHINA DNA & GENE CHIP MARKET SIZE, BY MANUFACTURING & CUSTOMIZATION, 2018-2030 (USD MILLION)
TABLE 267. INDIA DNA & GENE CHIP MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 268. INDIA DNA & GENE CHIP MARKET SIZE, BY BIOINFORMATICS TOOLS, 2018-2030 (USD MILLION)
TABLE 269. INDIA DNA & GENE CHIP MARKET SIZE, BY DNA MICROARRAYS, 2018-2030 (USD MILLION)
TABLE 270. INDIA DNA & GENE CHIP MARKET SIZE, BY GENE EXPRESSION PROFILING, 2018-2030 (USD MILLION)
TABLE 271. INDIA DNA & GENE CHIP MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 272. INDIA DNA & GENE CHIP MARKET SIZE, BY HYBRIDIZATION-BASED, 2018-2030 (USD MILLION)
TABLE 273. INDIA DNA & GENE CHIP MARKET SIZE, BY SEQUENCING-BASED, 2018-2030 (USD MILLION)
TABLE 274. INDIA DNA & GENE CHIP MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. INDIA DNA & GENE CHIP MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 276. INDIA DNA & GENE CHIP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 277. INDIA DNA & GENE CHIP MARKET SIZE, BY GOVERNMENT & OTHERS, 2018-2030 (USD MILLION)
TABLE 278. INDIA DNA & GENE CHIP MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 279. INDIA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. INDIA DNA & GENE CHIP MARKET SIZE, BY EPIGENOMICS, 2018-2030 (USD MILLION)
TABLE 281. INDIA DNA & GENE CHIP MARKET SIZE, BY GENE EXPRESSION ANALYSIS, 2018-2030 (USD MILLION)
TABLE 282. INDIA DNA & GENE CHIP MARKET SIZE, BY GENOTYPING, 2018-2030 (USD MILLION)
TABLE 283. INDIA DNA & GENE CHIP MARKET SIZE, BY PATHOGEN DETECTION, 2018-2030 (USD MILLION)
TABLE 284. INDIA DNA & GENE CHIP MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 285. INDIA DNA & GENE CHIP MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 286. INDIA DNA & GENE CHIP MARKET SIZE, BY DATA ANALYSIS & INTERPRETATION, 2018-2030 (USD MILLION)
TABLE 287. INDIA DNA & GENE CHIP MARKET SIZE, BY MANUFACTURING & CUSTOMIZATION, 2018-2030 (USD MILLION)
TABLE 288. INDONESIA DNA & GENE CHIP MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 289. INDONESIA DNA & GENE CHIP MARKET SIZE, BY BIOINFORMATICS TOOLS, 2018-2030 (USD MILLION)
TABLE 290. INDONESIA DNA & GENE CHIP MARKET SIZE, BY DNA MICROARRAYS, 2018-2030 (USD MILLION)
TABLE 291. INDONESIA DNA & GENE CHIP MARKET SIZE, BY GENE EXPRESSION PROFILING, 2018-2030 (USD MILLION)
TABLE 292. INDONESIA DNA & GENE CHIP MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 293. INDONESIA DNA & GENE CHIP MARKET SIZE, BY HYBRIDIZATION-BASED, 2018-2030 (USD MILLION)
TABLE 294. INDONESIA DNA & GENE CHIP MARKET SIZE, BY SEQUENCING-BASED, 2018-2030 (USD MILLION)
TABLE 295. INDONESIA DNA & GENE CHIP MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 296. INDONESIA DNA & GENE CHIP MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 297. INDONESIA DNA & GENE CHIP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 298. INDONESIA DNA & GENE CHIP MARKET SIZE, BY GOVERNMENT & OTHERS, 2018-2030 (USD MILLION)
TABLE 299. INDONESIA DNA & GENE CHIP MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 300. INDONESIA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 301. INDONESIA DNA & GENE CHIP MARKET SIZE, BY EPIGENOMICS, 2018-2030 (USD MILLION)
TABLE 302. INDONESIA DNA & GENE CHIP MARKET SIZE, BY GENE EXPRESSION ANALYSIS, 2018-2030 (USD MILLION)
TABLE 303. INDONESIA DNA & GENE CHIP MARKET SIZE, BY GENOTYPING, 2018-2030 (USD MILLION)
TABLE 304. INDONESIA DNA & GENE CHIP MARKET SIZE, BY PATHOGEN DETECTION, 2018-2030 (USD MILLION)
TABLE 305. INDONESIA DNA & GENE CHIP MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 306. INDONESIA DNA & GENE CHIP MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 307. INDONESIA DNA & GENE CHIP MARKET SIZE, BY DATA ANALYSIS & INTERPRETATION, 2018-2030 (USD MILLION)
TABLE 308. INDONESIA DNA & GENE CHIP MARKET SIZE, BY MANUFACTURING & CUSTOMIZATION, 2018-2030 (USD MILLION)
TABLE 309. JAPAN DNA & GENE CHIP MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 310. JAPAN DNA & GENE CHIP MARKET SIZE, BY BIOINFORMATICS TOOLS, 2018-2030 (USD MILLION)
TABLE 311. JAPAN DNA & GENE CHIP MARKET SIZE, BY DNA MICROARRAYS, 2018-2030 (USD MILLION)
TABLE 312. JAPAN DNA & GENE CHIP MARKET SIZE, BY GENE EXPRESSION PROFILING, 2018-2030 (USD MILLION)
TABLE 313. JAPAN DNA & GENE CHIP MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 314. JAPAN DNA & GENE CHIP MARKET SIZE, BY HYBRIDIZATION-BASED, 2018-2030 (USD MILLION)
TABLE 315. JAPAN DNA & GENE CHIP MARKET SIZE, BY SEQUENCING-BASED, 2018-2030 (USD MILLION)
TABLE 316. JAPAN DNA & GENE CHIP MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 317. JAPAN DNA & GENE CHIP MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 318. JAPAN DNA & GENE CHIP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 319. JAPAN DNA & GENE CHIP MARKET SIZE, BY GOVERNMENT & OTHERS, 2018-2030 (USD MILLION)
TABLE 320. JAPAN DNA & GENE CHIP MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 321. JAPAN DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 322. JAPAN DNA & GENE CHIP MARKET SIZE, BY EPIGENOMICS, 2018-2030 (USD MILLION)
TABLE 323. JAPAN DNA & GENE CHIP MARKET SIZE, BY GENE EXPRESSION ANALYSIS, 2018-2030 (USD MILLION)
TABLE 324. JAPAN DNA & GENE CHIP MARKET SIZE, BY GENOTYPING, 2018-2030 (USD MILLION)
TABLE 325. JAPAN DNA & GENE CHIP MARKET SIZE, BY PATHOGEN DETECTION, 2018-2030 (USD MILLION)
TABLE 326. JAPAN DNA & GENE CHIP MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 327. JAPAN DNA & GENE CHIP MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 328. JAPAN DNA & GENE CHIP MARKET SIZE, BY DATA ANALYSIS & INTERPRETATION, 2018-2030 (USD MILLION)
TABLE 329. JAPAN DNA & GENE CHIP MARKET SIZE, BY MANUFACTURING & CUSTOMIZATION, 2018-2030 (USD MILLION)
TABLE 330. MALAYSIA DNA & GENE CHIP MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 331. MALAYSIA DNA & GENE CHIP MARKET SIZE, BY BIOINFORMATICS TOOLS, 2018-2030 (USD MILLION)
TABLE 332. MALAYSIA DNA & GENE CHIP MARKET SIZE, BY DNA MICROARRAYS, 2018-2030 (USD MILLION)
TABLE 333. MALAYSIA DNA & GENE CHIP MARKET SIZE, BY GENE EXPRESSION PROFILING, 2018-2030 (USD MILLION)
TABLE 334. MALAYSIA DNA & GENE CHIP MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 335. MALAYSIA DNA & GENE CHIP MARKET SIZE, BY HYBRIDIZATION-BASED, 2018-2030 (USD MILLION)
TABLE 336. MALAYSIA DNA & GENE CHIP MARKET SIZE, BY SEQUENCING-BASED, 2018-2030 (USD MILLION)
TABLE 337. MALAYSIA DNA & GENE CHIP MARKET SIZE, BY END USER, 2018-2030 (USD MI

Companies Mentioned

  • 23andMe, Inc.
  • Agilent Technologies, Inc.
  • Arrayit Corporation
  • Biomérieux SA
  • Bioneer Corporation
  • CapitalBio Technology Co., Ltd.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • Greiner Bio-One International GmbH
  • Illumina, Inc.
  • Integrated Dna Technologies
  • LifeGen Technologies, LLC
  • Macrogen Inc.
  • Merck KGaA
  • Microarrays Inc.
  • Ocimum Biosolutions Ltd.
  • Perkin Elmer, Inc.
  • Promega Corporation
  • Savyon Diagnostics
  • Scienion AG by a Bico Company
  • Shanghai Biochip Co Ltd.
  • Sophia Genetics SA
  • Surmodics Inc.
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation
  • Veritas Genetics, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

DNA and Gene Chip - Global Strategic Business Report - Product Image

DNA and Gene Chip - Global Strategic Business Report

  • Report
  • 88 Pages
  • Global
From
DNA and Gene Chip Market Report 2025 - Product Image

DNA and Gene Chip Market Report 2025

  • Report
  • 200 Pages
  • Global
From
DNA & Gene Chip Market by Product, Type, by Application, by End-User, and By Region - Product Image

DNA & Gene Chip Market by Product, Type, by Application, by End-User, and By Region

  • Report
  • 200 Pages
  • Global
From
Gene Expression Market Report 2025 - Product Image

Gene Expression Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.